Geron Wins Patent Interference Vs. ACT Over Cloning Technology
This week, the Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office issued a final judgment in favor of Geron in a dispute involving patent claims to nuclear transfer technology. The board found that all claims of ACT’s patent, which it licenses from the University of Massachusetts, are be unpatentable, Geron said.
Geron has already received similarly favorable...
To view the full article, register now.